Close
ACHEMA MIDDLE EAST 2026

SP Industries Acquires Spanish Sterile Filling Line Company i-Dositecno

AI Summary

SP Industries (SP), a PA-based designer and manufacturer of laboratory equipment, pharmaceutical fill/finish manufacturing solutions, laboratory supplies, and glassware, announced in press release that it acquired the assets of privately held i-Dositecno, a global provider of sterile filling lines for pharmaceutical, cosmetic, and ophthalmic applications located in Mataro, Spain.

i-Dositecno has a well-earned reputation for producing high quality, fill/finish equipment complemented by strong software engineering capabilities and innovative servicing and support, stated SP CEO Brian Larkin in the release. He said that the i-Dositecno’s portfolio, engineering expertise, and liquid filling capabilities complement SP’s freeze dryers and aseptic vial processing lines.

As biological drug development and treatment protocols have become more specialized, we expect short-run aseptic liquid filling to continue to drive pharmaceutical growth, said Larkin in the release. With the addition of i-Dositecno to our SP brand, we now join a very select group of manufacturers with the capability to provide full lines. And, while SP has traditionally had a stronger equipment footprint in the United States, i-Dositecno’s efforts and success have primarily been within Europe and Asia.

These relationships, as well as the addition of a Spain location to our current UK manufacturing within Europe, provide significant opportunity to better serve the worldwide market. Key manufacturing, engineering, sales, and service personnel from i-Dositecno have joined the SP team to assure continuity in operations and service. Oriol Casoliva, founder and past CEO of i-Dositecno, will join SP’s Executive Leadership Team, and we look forward to benefiting from his vision and depth of knowledge in maximizing i-Dositecno and SP’s performance within the aseptic pharmaceutical manufacturing space.

Senior pharmaceutical decision - makers don’t consume every piece of content. They have sources they trust. Pharma Advancement is one of them.

Reaching this audience means appearing where they already are — inside trusted editorial that covers the full pharmaceutical and life sciences value chain. Our 2026 Media Pack shows you where to be seen:

Magazine & Digital

Where pharmaceutical decision - makers go to understand what’s coming next. Your brand belongs in that conversation.

Insights & Reports

The analysis and research the sector references when it matters most. Being part of it positions you differently.

Brand Authority

The companies that show up consistently in trusted editorial don’t need to explain who they are. They already are.

SUBSCRIBE OUR NEWSLETTER

WHITE PAPERS

RELATED ARTICLES